보고서 요약(국문)

개요
전 세계 ESR 분석기 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 보이며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
적혈구 침강 속도(ESR) 분석기는 전혈 내 적혈구가 표준 튜브로 가라앉는 속도를 측정하는 의료 기기로, 시간당 mm 단위로 보고됩니다. 이 검사는 염증을 측정하는 데 사용되는데, 염증이 있는 적혈구는 정상 적혈구에 비해 빠르게 침강합니다. 높은 ESR은 염증이 증가했음을 나타낼 수 있지만, 빈혈, 신부전, 비만과 같은 다른 질환도 ESR 수치를 증가시킬 수 있습니다.
ESR 검사에서 적혈구가 정상보다 빠르게 침강하는 것으로 나타나면 염증을 유발하는 질환이 있음을 의미합니다. 검사 결과의 속도는 염증 정도에 따라 달라집니다. ESR 수치가 빠를수록 염증 수준이 높다는 것을 의미합니다. 하지만 ESR 검사만으로는 염증의 원인을 정확히 진단할 수 없습니다. ESR 검사는 다른 검사와 함께 사용하여 염증을 유발하는 질환을 진단하는 데 도움을 줄 수 있습니다. 이러한 분석기는 관절염, 혈관염, 감염, 염증성 장 질환 등 다양한 염증성 질환을 진단하는 데 사용됩니다. 또한 기존 질환의 경과를 모니터링하는 데에도 활용될 수 있습니다.
시장 동향: 성장 요인
고급 ESR 분석기 도입 증가
고급 ESR 분석기 도입이 증가함에 따라 향후 시장 성장이 촉진될 것으로 예상됩니다. 이러한 고급 ESR 분석기는 일반적으로 ESR 검사 및 측정에서 더 높은 정확도와 정밀도를 제공합니다. 이는 다양한 유형의 염증성 질환과 같은 여러 질환의 정확한 진단 및 모니터링에 매우 중요합니다. 따라서 이러한 고급 분석기는 다양한 질환 진단에 더욱 널리 사용될 것으로 기대됩니다.
예를 들어, 세계적인 의료 솔루션 제공업체인 Mindray는 2022년 3월 14일 적혈구 침강 속도(ESR) 검사 기능을 통합한 혁신적인 혈액 분석기 시리즈인 BC-700 시리즈를 출시했습니다. BC-700/BC-720 개방형 바이알 모델과 BC-760/BC-780 자동 로더 모델 두 가지를 포함하는 이 시리즈는 프리미엄 제품에 적용되는 고급 진단 기술을 통해 중규모 실험실의 역량을 강화하도록 설계되었습니다.
또한, 많은 고급 ESR 분석기는 일반적으로 자동화되어 있어 결과를 더 빠르게 제공할 수 있습니다. 이는 특히 위급한 상황에서 신속한 진단 및 치료 결정으로 이어질 수 있습니다. 고급 ESR 분석기는 임상 실험실에서 더 많은 양의 검사를 보다 효율적으로 처리할 수 있도록 하여 처리량(throughput)이 높은 것으로 알려져 있습니다.
예를 들어, 2022년 5월 20일, Transasia Bio-Medicals Ltd는 성장하는 체외 진단 포트폴리오에 Erba XL 640과 ESL 30이라는 두 가지 신제품을 출시했습니다. Transasia는 ESR 포트폴리오에서 워크플로, 처리 시간 및 실험실 안전성을 향상시키는 터치스크린 인터페이스를 갖춘 완전 자동화 ESR 분석 시스템인 ESL 30을 출시한다고 발표했습니다.

또한, 염증성 질환의 유병률 증가, 더욱 발전된 ESR 분석기에 대한 FDA 승인 증가, ESR 분석기의 장점에 대한 인식 제고, 그리고 ESR 분석기의 기술 발전은 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
제약 요인
ESR 분석기와 관련된 합병증, 높은 가격, 많은 양의 구연산나트륨 필요성, 그리고 최소 1시간 이상의 긴 검사 시간은 예측 기간 동안 시장 성장을 저해할 것으로 예상되는 요인입니다.
세분화 분석
글로벌 ESR 분석기 시장은 제품 유형, 측정 방법, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
자동 ESR 분석기 부문은 ESR 분석기 시장 점유율의 약 47.4%를 차지했습니다.
자동 ESR 분석기 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 자동 ESR 분석기는 다른 반자동 및 수동 방식에 비해 특히 ESR 측정에서 높은 정확도와 정밀도를 제공하는 것으로 잘 알려져 있습니다. 이는 진단 목적에 중요한 신뢰할 수 있고 신속하며 정확한 검사 결과를 얻는 데 필수적입니다.
예를 들어, 니혼코덴은 2020년 12월 21일 자동 혈액 및 ESR 분석기인 MEK-1305 셀탁 α+를 출시했습니다. MEK-1305는 백혈구 3분위 감별을 포함한 전체 혈구 수(CBC)와 적혈구 침강 속도(ESR)를 동시에 측정할 수 있는 세계 최초의 혈액 분석기입니다. 니혼코덴은 환자의 임상 상태를 파악하는 데 중요한 신속하고 정확한 검사 결과를 제공한다는 개념을 바탕으로 MEK-1305를 개발했습니다.
또한, 이러한 자동 ESR 분석기는 시간을 절약하여 ESR 검사를 더 빠르고 효율적으로 수행하도록 특별히 설계되었습니다. 자동 ESR 분석기는 튜브 크기, 기울기 각도, 실내 온도와 같은 요인이 결과에 영향을 미칠 수 있는 변동성을 최소화합니다. 이러한 분석기는 일반적으로 처리량이 높아 실험실에서 더 짧은 시간 안에 더 많은 양의 샘플을 처리할 수 있습니다. 또한, ESR 분석기의 광범위한 도입은 자동 ESR 분석기에 대한 수요 증가로 이어지고 있습니다.
지역 분석
북미는 시장 점유율의 약 41.2%를 차지했습니다.
북미 지역은 주요 업체들의 강력한 입지와 ESR 분석기에 대한 수요 증가로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 특히 미국은 신속하고 정확한 검사 결과를 제공하는 더욱 발전된 ESR 분석기 개발에 주력하는 의료기기 회사와 같은 주요 업체들의 강력한 입지를 자랑합니다.
또한, ESR 분석기에 대한 지속적인 수요 증가는 이 지역 시장 성장을 견인할 것으로 예상됩니다. ESR 분석기는 거대 세포 동맥염 진단에 가장 일반적으로 사용됩니다. 미국에서 거대 세포 동맥염 발병률이 증가함에 따라 더욱 신속하고 정확한 검사 결과를 제공하는 ESR 분석기에 대한 수요가 증가하고 있으며, 이는 이 지역 시장 성장을 더욱 촉진할 것입니다.

예를 들어, 미국 국립보건원(NIH)에 따르면 미국에서 거대세포동맥염(GCA)의 연간 발병률은 10만 명당 18.9명으로 추정되며, 유병률은 10만 명당 228명으로 추정됩니다. 2050년까지 미국에서 약 95만 명이 GCA 진단을 받고, 14만 명이 GCA로 인해 시력 손상을 입을 것으로 예상됩니다.
경쟁 환경
ESR 분석기 시장의 주요 글로벌 업체로는 Cardinal Health, Inc., Medsource Ozone Biomedicals Pvt. Ltd., Labtron Equipment Ltd., Carolina Liquid Chemistries Corp., Thermo Fisher Scientific Inc., Zimed Healthcare Inc., ALCOR Scientific Inc., Alifax S.r.l., Q-line Biotech Pvt Ltd. 및 Caretium Medical Instruments Co. 등이 있습니다.

COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 ESR 분석기 시장에 상당한 영향을 미쳤습니다. 팬데믹 기간 동안 ESR 분석기를 포함한 진단 장비에 대한 수요가 증가하여 시장에 긍정적인 영향을 미쳤습니다. COVID-19 상황에서는 COVID-19 환자 유입과 다양한 염증성 질환 모니터링의 필요성으로 인해 ESR 분석기와 같은 진단 도구에 대한 수요가 증가했습니다. 또한 팬데믹은 전 세계적으로 이러한 장비의 공급망을 교란시켰습니다.

시장 세분화
제품 유형별
• 자동 ESR 분석기
• 반자동 ESR 분석기
• 수동 ESR 분석기
측정 방법별
• 웨스터그렌법
• 윈트로브법
적용 분야별
• 거대세포동맥염
• 다발성 근육통
• 류마티스 관절염
• 결핵
• 전신성 홍반성 루푸스
• 기타
최종 사용자별
• 병원
• 진단 실험실
• 연구 및 학술 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
보고서 구매 이유

• 제품 유형, 방법, 적용 분야, 최종 사용자 및 지역별 글로벌 ESR 분석기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트를 포함한 ESR 분석기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 ESR 분석기 시장 보고서는 약 69개의 표, 70개의 그림, 187페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global ESR analyzers market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
The erythrocyte sedimentation rate analyzers which is also known as the ESR analyzers, are the medical devices used for a clinical lab test that measures the rate at which red blood cells in whole blood descend into a standardized tube, reported as mm per hour. This test is used to measure inflammation as inflamed red blood cells settle quickly relative to normal blood cells. A high ESR can be indicative of elevated inflammation, though other conditions such as anemia, renal failure, and obesity can increase the ESR rate as well.
If an ESR test shows that the red blood cells sink faster than normal, it means that the medical condition causing inflammation. The speed of the test result is based on inflammation. Faster ESR rates mean higher levels of inflammation. However, an ESR test alone cannot diagnose what condition is causing the inflammation. An ESR test can be used with other tests to help diagnose conditions that cause inflammation. These analyzers are used to diagnose many types of conditions that cause inflammation, including arthritis, vasculitis, infection and inflammatory bowel disease. ESR analyzers also be used to monitor an existing condition.
Market Dynamics: Drivers
Increasing adoption of advanced ESR analyzers
The increasing adoption of advanced ESR analyzers is expected to drive the market over the forecast period. These advanced ESR analyzers typically offer higher levels of accuracy and precision in ESR testing and measurements. This is very crucial for the accurate diagnosis and monitoring of various medical conditions such as various types of inflammatory diseases. Thus, these advanced analyzers are more prone to be adopted for various medical conditions.
For instance, on March 14, 2022, Mindray, a global leading medical solution provider, launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.
In addition, many advanced ESR analyzers are usually automated and can provide results more quickly. This can lead to quicker diagnosis and treatment decisions, which is especially important in critical conditions. Advanced ESR analyzers are known to have higher throughput capabilities by allowing clinical laboratories to process a larger volume of tests more efficiently.
For instance, on May 20, 2022, Transasia Bio-Medicals Ltd launched two new products in its growing portfolio of in vitro diagnostics, Erba XL 640 and ESL 30. In its ESR portfolio, Transasia announced the launch of ESL 30, a truly automated ESR analyzer system with a touchscreen interface that improves workflow, turnaround time and laboratory safety.
Further, the increasing prevalence of inflammation disorders, rising FDA approvals for the more advanced ESR analyzers, increasing awareness about the advantages of the ESR analyzers and technological advancements in ESR analyzers are expected to drive the market over the forecast period.
Restraints
Factors such as complications associated with the ESR analyzers, the high cost of the ESR analyzers, these analyzers requiring a large volume of sodium citrate and high testing time that is it requires at least 1 hour of testing time are the factors expected to hamper the market over the forecast period.
Segment Analysis
The global ESR analyzers market is segmented based on product type, method, application, end-user and region.
The automated ESR analyzer segment accounted for approximately 47.4% of the ESR analyzers market share
The automated ESR analyzer segment is expected to hold the largest market share over the forecast period. Automated ESR analyzers are very well known for their higher accuracy and precision especially in ESR measurements compared to other semi-automated and manual methods. This is crucial for reliable, rapid and accurate test results, which are important for diagnostic purposes.
For instance, on December 21, 2020, Nihon Kohden launched MEK-1305 Celltac α+, an Automated Hematology and ESR Analyzer. MEK-1305 is the world’s first hematology analyzer that can measure complete blood count (CBC) including white blood cell 3-part differential and erythrocyte sedimentation rate (ESR) simultaneously. The Company developed MEK-1305 based on the concept of providing rapid and accurate test results, which are important for understanding the clinical condition of patients.
Moreover, these automated ESR analyzers are specifically designed to perform ESR tests quickly and more efficiently by saving time. Automated ESR analyzers minimize the variability, where factors like tube size, tilt angle, and room temperature can affect results. These analyzers often have a higher throughput capacity, allowing laboratories to process a larger volume of samples in a shorter time. In addition, their wide adoption also increases the demand for automated ESR analyzers.
Geographical Analysis
North America accounted for approximately 41.2% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing demand for ESR analyzers in the region. North America especially the United States is known for its strong presence of major players such as medical device companies which mainly focus on the development of more advanced ESR analyzers that provide rapid and accurate test results.
In addition, there is a continuously increasing demand for ESR analyzers, which is expected to drive the market in the region. The ESR analyzers are most commonly used in the diagnosis of giant cell arteritis. There is an increasing prevalence of giant cell arteritis in the United States, which increases the demand for ESR analyzers for better, rapid and accurate test results, this further driving the market in the region.
For instance, according to the National Institute of Health (NIH), the annual incidence of Giant cell arteritis (GCA) in the US is estimated to be 18.9 per 100,000, and the estimated prevalence is 228 per 100,000. It is estimated that nearly 950,000 individuals will be diagnosed with GCA and 140,000 will become visually impaired because of GCA in the US upto 2050.
Competitive Landscape
The major global players in the ESR analyzers market include Cardinal Health, Inc., Medsource Ozone Biomedicals Pvt. Ltd., Labtron Equipment Ltd., Carolina Liquid Chemistries Corp., Thermo Fisher Scientific Inc., Zimed Healthcare Inc., ALCOR Scientific Inc., Alifax S.r.l., Q-line Biotech Pvt Ltd. and Caretium Medical Instruments Co. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global ESR analyzers market. During the pandemic, there is an increased need for diagnostic equipment including ESR analyzers, which positively impacted the market. In COVID-19 situations, there is an increased requirement for more diagnostic tools like ESR analyzers to cope with the influx of COVID-19 patients and the need to monitor many inflammatory conditions. The pandemic also disrupted the supply chain of these devices globally.
Market Segmentation
By Product Type
• Automated ESR Analyzer
• Semi-Automated ESR Analyzer
• Manual ESR Analyzer
By Method
• Westergren Method
• Wintrobe Method
By Application
• Giant Cell Arteritis
• Polymyalgia Rheumatica
• Rheumatoid Arthritis
• Tuberculosis
• Systemic Lupus Erythematosus
• Others
By End-User
• Hospitals
• Diagnostic Laboratories
• Research and Academic Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global ESR analyzers market segmentation based on product type, method, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of ESR analyzers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global ESR analyzers market report would provide approximately 69 tables, 70 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Method
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption of Advanced ESR Analyzers
4.1.2. Restraints
4.1.2.1. High Cost of the ESR Analyzers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. Volume Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Automated ESR Analyzer*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automated ESR Analyzer
7.4. Manual ESR Analyzer
8. By Method
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
8.1.2. Market Attractiveness Index, By Method
8.2. Westergren Method*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Wintrobe Method
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Giant Cell Arteritis*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Polymyalgia Rheumatica
9.4. Rheumatoid Arthritis
9.5. Tuberculosis
9.6. Systemic Lupus Erythematosus
9.7. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic Laboratories
10.4. Research and Academic Institutes
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Cardinal Health, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Medsource Ozone Biomedicals Pvt. Ltd.
13.3. Labtron Equipment Ltd.
13.4. Carolina Liquid Chemistries Corp.
13.5. Thermo Fisher Scientific Inc.
13.6. Zimed Healthcare Inc.
13.7. ALCOR Scientific Inc.
13.8. Alifax S.r.l.
13.9. Q-line Biotech Pvt Ltd.
13.10. Caretium Medical Instruments Co.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Cardinal Health, Inc., 4.	Key Developments, Medsource Ozone Biomedicals Pvt. Ltd., Labtron Equipment Ltd., Carolina Liquid Chemistries Corp., Thermo Fisher Scientific Inc., Zimed Healthcare Inc., ALCOR Scientific Inc., Alifax S.r.l., Q-line Biotech Pvt Ltd., Caretium Medical Instruments Co.

표 목록 (Tables)

List of Tables

Table 1 Global ESR Analyzers Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global ESR Analyzers Market Value, By Method, 2023, 2027 & 2031 (US$ Million)

Table 3 Global ESR Analyzers Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global ESR Analyzers Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global ESR Analyzers Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global ESR Analyzers Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global ESR Analyzers Market Value, By Method, 2023, 2027 & 2031 (US$ Million)

Table 9 Global ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 10 Global ESR Analyzers Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global ESR Analyzers Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global ESR Analyzers Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global ESR Analyzers Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 18 North America ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America ESR Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 South America ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 23 South America ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America ESR Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 28 Europe ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe ESR Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 33 Asia-Pacific ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific ESR Analyzers Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa ESR Analyzers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa ESR Analyzers Market Value, By Method, 2022-2031 (US$ Million)

Table 38 Middle East & Africa ESR Analyzers Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa ESR Analyzers Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Cardinal Health, Inc.: Overview

Table 41 Cardinal Health, Inc.: Product Portfolio

Table 42 Cardinal Health, Inc.: Key Developments

Table 43 Medsource Ozone Biomedicals Pvt. Ltd.: Overview

Table 44 Medsource Ozone Biomedicals Pvt. Ltd.: Product Portfolio

Table 45 Medsource Ozone Biomedicals Pvt. Ltd.: Key Developments

Table 46 Labtron Equipment Ltd.: Overview

Table 47 Labtron Equipment Ltd.: Product Portfolio

Table 48 Labtron Equipment Ltd.: Key Developments

Table 49 Carolina Liquid Chemistries Corp.: Overview

Table 50 Carolina Liquid Chemistries Corp.: Product Portfolio

Table 51 Carolina Liquid Chemistries Corp.: Key Developments

Table 52 Thermo Fisher Scientific Inc.: Overview

Table 53 Thermo Fisher Scientific Inc.: Product Portfolio

Table 54 Thermo Fisher Scientific Inc.: Key Developments

Table 55 Zimed Healthcare Inc.: Overview

Table 56 Zimed Healthcare Inc.: Product Portfolio

Table 57 Zimed Healthcare Inc.: Key Developments

Table 58 ALCOR Scientific Inc.: Overview

Table 59 ALCOR Scientific Inc.: Product Portfolio

Table 60 ALCOR Scientific Inc.: Key Developments

Table 61 Alifax S.r.l.: Overview

Table 62 Alifax S.r.l.: Product Portfolio

Table 63 Alifax S.r.l.: Key Developments

Table 64 Q-line Biotech Pvt Ltd.: Overview

Table 65 Q-line Biotech Pvt Ltd.: Product Portfolio

Table 66 Q-line Biotech Pvt Ltd.: Key Developments

Table 67 Caretium Medical Instruments Co.: Overview

Table 68 Caretium Medical Instruments Co.: Product Portfolio

Table 69 Caretium Medical Instruments Co.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 2 Global ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 4 Global ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 6 Global ESR Analyzers Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global ESR Analyzers Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Automated ESR Analyzer ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 9 Semi-Automated ESR Analyzer ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 10 Manual ESR Analyzer ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 11 Global ESR Analyzers Market Y-o-Y Growth, By Method, 2022-2031 (%)

Figure 12 Westergren Method Method in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 13 Wintrobe Method Method in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 14 Global ESR Analyzers Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 15 Giant Cell Arteritis Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 16 Polymyalgia Rheumatica Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 17 Rheumatoid Arthritis Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 18 Tuberculosis Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 19 Systemic Lupus Erythematosus Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 20 Others Application in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 21 Global ESR Analyzers Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 22 Hospitals End-User in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 23 Diagnostic Laboratories End-User in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 24 Research and Academic Institutes End-User in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 25 Others End-User in Global ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 26 Global ESR Analyzers Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 27 North America ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 29 Europe ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 30 South America ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 32 North America ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 33 North America ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 34 North America ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 35 North America ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 36 North America ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 37 North America ESR Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 38 South America ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 39 South America ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 40 South America ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 41 South America ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 42 South America ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 43 South America ESR Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 44 Europe ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 45 Europe ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 46 Europe ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 47 Europe ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 48 Europe ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 49 Europe ESR Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 50 Asia-Pacific ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 51 Asia-Pacific ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 52 Asia-Pacific ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 53 Asia-Pacific ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 54 Asia-Pacific ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 55 Asia-Pacific ESR Analyzers Market Share, By Country, 2022 & 2031 (%)

Figure 56 Middle East & Africa ESR Analyzers Market Value, 2022-2031 (US$ Million)

Figure 57 Middle East & Africa ESR Analyzers Market Share, By Product Type, 2022 & 2031 (%)

Figure 58 Middle East & Africa ESR Analyzers Market Share, By Method, 2022 & 2031 (%)

Figure 59 Middle East & Africa ESR Analyzers Market Share, By Application, 2022 & 2031 (%)

Figure 60 Middle East & Africa ESR Analyzers Market Share, By End-User, 2022 & 2031 (%)

Figure 61 Cardinal Health, Inc.: Financials

Figure 62 Medsource Ozone Biomedicals Pvt. Ltd.: Financials

Figure 63 Labtron Equipment Ltd.: Financials

Figure 64 Carolina Liquid Chemistries Corp.: Financials

Figure 65 Thermo Fisher Scientific Inc.: Financials

Figure 66 Zimed Healthcare Inc.: Financials

Figure 67 ALCOR Scientific Inc.: Financials

Figure 68 Alifax S.r.l.: Financials

Figure 69 Q-line Biotech Pvt Ltd.: Financials

Figure 70 Caretium Medical Instruments Co.: Financials

글로벌 ESR 분석기 시장 – 2023-2030

Global ESR Analyzers Market - 2023-2030